BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nair D, Finkelstein FO. Pruritus as a Patient-Reported Primary Trial End Point in Hemodialysis: Evaluation and Implications. Am J Kidney Dis 2020;76:148-51. [PMID: 32334827 DOI: 10.1053/j.ajkd.2020.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wala K, Szepietowski JC. Difelikefalin in the Treatment of Chronic Kidney Disease-Associated Pruritus: A Systematic Review. Pharmaceuticals 2022;15:934. [DOI: 10.3390/ph15080934] [Reference Citation Analysis]
2 Poku E, Harnan S, Rooney G, James MM, Hernández-alava M, Schaufler T, Thokala P, Fotheringham J. The relationship between chronic kidney disease–associated pruritus and health-related quality of life: a systematic review. Clinical Kidney Journal 2021. [DOI: 10.1093/ckj/sfab218] [Reference Citation Analysis]